Lexicon Pharmaceuticals
LXRX
#6259
Rank
NZ$1.81 B
Marketcap
NZ$4.08
Share price
-2.83%
Change (1 day)
132.94%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total assets

Total assets on the balance sheet as of March 2026 : NZ$0.45 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's total assets are NZ$0.45 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Lexicon Pharmaceuticals - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31NZ$0.31 B-39.64%
2024-12-31NZ$0.52 B45.85%
2023-12-31NZ$0.36 B18.55%
2022-12-31NZ$0.30 B52.68%
2021-12-31NZ$0.20 B-29.03%
2020-12-31NZ$0.28 B-54.46%
2019-12-31NZ$0.62 B46.42%
2018-12-31NZ$0.42 B-31.09%
2017-12-31NZ$0.61 B-10.48%
2016-12-31NZ$0.68 B-27.92%
2015-12-31NZ$0.95 B58.34%
2014-12-31NZ$0.60 B80.33%
2013-12-31NZ$0.33 B-26.18%
2012-12-31NZ$0.45 B-18.07%
2011-12-31NZ$0.55 B15.99%
2010-12-31NZ$0.47 B34%
2009-12-31NZ$0.35 B-21.25%
2008-12-31NZ$0.45 B-6.53%
2007-12-31NZ$0.48 B78.51%
2006-12-31NZ$0.27 B-15.6%
2005-12-31NZ$0.31 B7.71%
2004-12-31NZ$0.29 B-32.05%
2003-12-31NZ$0.43 B13.4%
2002-12-31NZ$0.38 B-33.29%
2001-12-31NZ$0.57 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Thermo Fisher Scientific
TMO
NZ$192.48 B 42,040.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$11.14 B 2,339.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$69.44 B 15,103.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
NZ$2.20 B 382.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$2.60 B 469.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$0.78 B 72.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ$0.63 B 39.72%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$14.59 B 3,095.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ$17.91 M-96.08%๐Ÿ‡บ๐Ÿ‡ธ USA